# A Study In Healthy Volunteers To Estimate The Effect Of The Active Ingredient Particle Size And Percentage Of The Excipients Used To Formulate The Capsules In The Dissolution Rate Of The Formulations In The Gastrointestinal Tract

> **NCT01844323** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Palbociclib Formulation Reference
- **OTHER:** Palbociclib Formulation Test
- **OTHER:** Palbociclib Formulation Test
- **OTHER:** Palbociclib Formulation Test

## Key facts

- **NCT ID:** NCT01844323
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01844323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01844323, "A Study In Healthy Volunteers To Estimate The Effect Of The Active Ingredient Particle Size And Percentage Of The Excipients Used To Formulate The Capsules In The Dissolution Rate Of The Formulations In The Gastrointestinal Tract". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01844323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*